Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Taub Rebecca. Insider active across 1 company, notably Madrigal Pharmaceuticals, INC.. Cumulatively, 11 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €657k. History available since 16 January 2023. The latest transaction was disclosed on 11 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Rebecca Taub is a declarant linked to Madrigal Pharmaceuticals, INC., where her listed role is Pres., R&D, and CMO. She has 8 filings in total, and across the 8 sampled filings between 2023-01-18 and 2025-03-07, sales total EUR 656814, with the modal transaction nature shown as Attribution.